Literature DB >> 31172202

[Suggested formulations for mometasone furoate combinations].

Stefanie Melhorn1, Petra Staubach2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31172202     DOI： 10.1007/s00105-019-4439-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  4 in total

Review 1.  [Glucocorticoid containing extemporaneous formulations. Rational for use in dermatology].

Authors:  Petra Högger
Journal:  Pharm Unserer Zeit       Date:  2010-07

2.  Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.

Authors:  J Koo; C A Cuffie; D J Tanner; R Bressinck; R C Cornell; R L DeVillez; L Edwards; D L Breneman; D J Piacquadio; C A Guzzo; E W Monroe
Journal:  Clin Ther       Date:  1998 Mar-Apr       Impact factor: 3.393

3.  [Suggested formulations for mometasone furoate].

Authors:  Stefanie Melhorn; Petra Staubach
Journal:  Hautarzt       Date:  2019-05       Impact factor: 0.751

4.  [Clotrimazole and ciclopirox olamine respectively in combination with methylprednisolone aceponate as extemporaneous formulations].

Authors:  J Wohlrab; R H H Neubert; E Sommer; J Michael
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.